Waldenstrom's Macroglobulinemia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM
Condition: Waldenstrom Macroglobulinemia Intervention: Drug: Zanubrutinib, Bendamustine and Rituximab Sponsor: Institute of Hematology & Blood Diseases Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
